Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Impact of Hypoglycaemia on Quality of Life in Adults With Type 1 Diabetes Using Contemporary Diabetes Technologies: A US National Survey.

Diabetes, obesity & metabolism·2026
Same author

Lessons From a Simulation Study Assessing Social Biases of Generative Artificial Intelligence.

The Journal of the Association of Nurses in AIDS Care : JANAC·2026
Same author

Study of Metformin and GLP-1 Receptor Agonist Use in Hidradenitis Suppurativa Using the NIH All of Us Research Program.

Diabetes care·2026
Same author

Comparative effectiveness of sulfonylureas on kidney outcomes in adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation.

BMJ open diabetes research & care·2026
Same author

Comparative Effectiveness of Individual Sodium Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: Emulation of a Target Trial.

Journal of the American Heart Association·2026
Same author

SGLT2i and GLP-1RA Use in the USA.

Journal of general internal medicine·2026
Same journal

Tetanus Health Information on YouTube and TikTok: Cross-Sectional Analysis of Quality, Reliability, and Public Health Implications.

JMIR infodemiology·2026
Same journal

Online Information Behavior Regarding COVID-19 Vaccination and Its Association With Vaccination Behavior Based on Cluster Analysis of User Groups: Cross-Sectional Study.

JMIR infodemiology·2026
Same journal

Early Depression Detection in Social Media: Monitoring of Individual Nighttime Dynamics and Large Language Model Analysis.

JMIR infodemiology·2026
Same journal

Japanese-Language AI Agent System for Human Papillomavirus Vaccine Infoveillance and Public Communication: Development and Feasibility Evaluation.

JMIR infodemiology·2026
Same journal

Performance of Large Language Models in the Cognitive Analysis of Misinformation: Evaluation Study.

JMIR infodemiology·2026
Same journal

Implementation and User Evaluation of the SANGYAN Digital Health Platform to Enhance Knowledge About COVID-19 and Other Health Conditions: Quasi-Experimental Study.

JMIR infodemiology·2026
See all related articles
  1. Home
  3. Exploring Weight Loss Medication Discourse: Mixed Methods Analysis Of Us-based Facebook Posts.
  1. Home
  3. Exploring Weight Loss Medication Discourse: Mixed Methods Analysis Of Us-based Facebook Posts.

Related Experiment Video

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Exploring Weight Loss Medication Discourse: Mixed Methods Analysis of US-Based Facebook Posts.

Elizabeth Dennard1, Katrina Makres1, Amrutha Alibilli1

  • 1Deparment of Epidemiology and Biostatistics, School of Public Health, University of Maryland, College Park, 4254 Stadium Drive, College Park, MD, 20742, United States.

JMIR Infodemiology
|May 8, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

Public narratives on Facebook reveal key themes regarding weight loss medications, including benefits, harms, and access. Enhanced education is crucial for the safe use of glucagon-like peptide-1 receptor agonists.

Keywords:
digital healthinternetobesityresearchweight loss

More Related Videos

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
08:53

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community

Published on: May 31, 2019

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Related Experiment Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
08:53

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community

Published on: May 31, 2019

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Area of Science:

  • Pharmacology
  • Sociology
  • Digital Health

Background:

  • Clinical efficacy of weight loss medications is established.
  • Limited large-scale studies explore patient experiences with these drugs.
  • Social media platforms offer insights into public discourse.

Purpose of the Study:

  • Examine public narratives on Facebook concerning glucagon-like peptide-1 receptor agonist (GLP-1 RA) use.
  • Identify perceived benefits, challenges, and identity-related experiences.
  • Analyze the sociocultural framing of GLP-1 RA in online discussions.

Main Methods:

  • Collected 2500 US-based Facebook posts (Jan 2022 - May 2024) using CrowdTangle.
  • Applied bidirectional encoder representations from transformers (BERT) for topic modeling.
  • Conducted qualitative thematic analysis to identify emergent themes.

    • Main Results:

    • Identified five subcategories: healthy weight management, weight loss medications, semaglutide, Ozempic, and public figures/media.
    • Thirteen overarching themes emerged, including weight management programs (n=702), neutral content (n=466), harms (n=373), benefits (n=329), and access (n=188).

    Conclusions:

    • Social media provides valuable insights into patient experiences with weight management pharmacotherapy.
    • Public education initiatives can improve the safe and effective use of GLP-1 RAs for weight loss.